Drug Shortage Report for ACT DEXTROAMPHETAMINE SR

Last updated on 2021-01-28 History
Report ID 129978
Drug Identification Number 02448319
Brand name ACT DEXTROAMPHETAMINE SR
Common or Proper name DEXTROAMPHETAMINE SRCAP 10MG
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) DEXTROAMPHETAMINE SULFATE
Strength(s) 10MG
Dosage form(s) CAPSULE (SUSTAINED-RELEASE)
Route of administration ORAL ORAL
Packaging size 100
ATC code N06BA
ATC description PSYCHOSTIMULANTS AND NOOTROPICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-12-09
Estimated end date 2021-01-31
Actual end date 2021-01-27
Shortage status Resolved
Updated date 2021-01-28
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2021-01-28 French Compare
v3 2021-01-28 English Compare
v2 2020-12-10 French Compare
v1 2020-12-10 English Compare

Showing 1 to 4 of 4